Federal Register Notice: FDA’s Anesthetic and Life Support Drugs Advisory Committee will meet 9/9-10 from 8 a.m. to 5 p.m. at the Holiday Inn, Bethesda, MD. On 9/9, the committee will discuss risk management plans for opiate analgesic drug products with particular attention to modified-release products. On 9/10, the committee will discuss the abuse liability of and risk management plans for Palladone, a modified-release hydromorphone drug product indicated for the treatment of moderate to severe pain in opioid tolerant patients. Contact Johanna M. Clifford, (301) 827-7001. To view this notice, click here.
